Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 335)
Posted On: 06/17/2020 5:29:37 PM
Post# of 36568
Posted By: skipper1072
Re: skipper1072 #17280
New BARDA Award: Ortho Clinical Diagnostics null
Product Name: VITROS® Anti-SARS-CoV-2 IgG Test
View Announcement


Description:
High-accuracy immunoassay for the qualitative detection of IgG antibodies to SARS-CoV-2 – which appear in later phases of infection and remain elevated after recovery – offered on random-access, high throughout laboratory instruments. One award of $678,000 is funding continued development of this assay and the Ortho total antibody test.


Unique Impact:
This immunoassay can be used to assess immune response for aiding in the diagnosis of COVID-19 infection, assessing seroprevalence, and for identifying who can donate convalescent plasma. It is offered on high-throughput laboratory instruments that do not require plumbing, for the greatest workflow advantages.


Status: EUA Issued


Award Amount: $678,000.00













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site